Primecap Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.78M | Buy |
|
|||||
|
2025
Q2 | $6.46M | Buy |
|
|||||
|
2025
Q1 | $7.2M | Buy |
|
|||||
|
2024
Q4 | $10.5M | Sell |
|
|||||
|
2024
Q3 | $15.9M | Sell |
|
|||||
|
2024
Q2 | $13.2M | Buy |
|
|||||
|
2024
Q1 | $24.4M | Buy |
|
|||||
|
2023
Q4 | $17M | Sell |
|
|||||
|
2023
Q3 | $16.8M | Sell |
|
|||||
|
2023
Q2 | $28M | Sell |
|
|||||
|
2023
Q1 | $28.5M | Buy |
|
|||||
|
2022
Q4 | $31.1M | Buy |
|
|||||
|
2022
Q3 | $52.8M | Buy |
|
|||||
|
2022
Q2 | $55.7M | Sell |
|
|||||
|
2022
Q1 | $44.7M | Buy |
|
|||||
|
2021
Q4 | $69.6M | Buy |
|
|||||
|
2021
Q3 | $92.6M | Buy |
|
|||||
|
2021
Q2 | $93.3M | Buy |
|
|||||
|
2021
Q1 | $46.1M | Buy |
|
|||||
|
2020
Q4 | $31.3M | Buy |
|